A provisional agreement by political authorities in the EU to support proposed legislation to improve the production and supply of critical medicines in the event of a disruption has been welcomed by the European Medicines Agency. Called the Critical Medicines Act, the legislation would spell out procedures for doing regular assessments of supply chains for the availability of essential medicines, identify vulnerabilities, and take steps to correct them. The EU has compiled a list of over 400 medicines which qualify as core products.
